114 related articles for article (PubMed ID: 1969869)
21. Double-blind trial of oral carbuterol in bronchial asthma.
Miller J; Wallace D; Grieco MH; Frenkel R; Larsen K
Ann Allergy; 1977 Jul; 39(1):12-7. PubMed ID: 18957
[TBL] [Abstract][Full Text] [Related]
22. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF
Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285
[TBL] [Abstract][Full Text] [Related]
23. Procaterol metered aerosol in patients with chronic obstructive pulmonary disease.
Baronti A; Lelli M; Manini G; Verdiani P
Int J Clin Pharmacol Res; 1987; 7(5):363-8. PubMed ID: 2889678
[TBL] [Abstract][Full Text] [Related]
24. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.
Lipworth BJ; Struthers AD; McDevitt DG
Am Rev Respir Dis; 1989 Sep; 140(3):586-92. PubMed ID: 2782734
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of procaterol combined with inhaled budesonide for treatment of cough-variant asthma.
Bao W; Chen Q; Lin Y; Liu H; Zhao G; Chen Z; Zhou X
Respirology; 2013 Nov; 18 Suppl 3():53-61. PubMed ID: 24188204
[TBL] [Abstract][Full Text] [Related]
26. A study with cumulative doses of formoterol and salbutamol in children with asthma.
Foucard T; Lönnerholm G
Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
[TBL] [Abstract][Full Text] [Related]
27. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
28. The effect of diet on the efficacy onset and duration of action of procaterol hydrochloride tablets.
Spangler DL; Lutz CN; Tinkelman D
Ann Allergy; 1987 Jan; 58(1):59-62. PubMed ID: 2948431
[TBL] [Abstract][Full Text] [Related]
29. [A new aerosol adrenergic bronchodilator, procaterol. Comparative study of salbutamol and procaterol].
Morin D; Milot J; Turcotte H; Boulet LP
Union Med Can; 1987 Apr; 116(4):215-8. PubMed ID: 2885957
[No Abstract] [Full Text] [Related]
30. The development of drug tolerance to beta2 adrenergic agents.
Plummer AL
Chest; 1978 Jun; 73(6 Suppl):949-57. PubMed ID: 28210
[No Abstract] [Full Text] [Related]
31. Spirometric comparison of carbuterol and isoproterenol aerosol therapy in bronchial asthma. A double blind, matched-pair study of 28 adults and a double blind crossover study of 18 children.
Rhoades RB; Leifer KN; Bloom FL; Wittig HJ
Am Rev Respir Dis; 1976 Jul; 114(1):79-86. PubMed ID: 7174
[TBL] [Abstract][Full Text] [Related]
32. Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease.
Dahl R; Earnshaw JS; Palmer JB
Eur Respir J; 1991 Nov; 4(10):1178-84. PubMed ID: 1687131
[TBL] [Abstract][Full Text] [Related]
33. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
Lebecque P; Vliers S; De Saint-Moulin T; Godding V
Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
[TBL] [Abstract][Full Text] [Related]
34. Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma.
Pohunek P; Kuna P; Jorup C; De Boeck K
Pediatr Allergy Immunol; 2006 Sep; 17(6):458-65. PubMed ID: 16925692
[TBL] [Abstract][Full Text] [Related]
35. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
36. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.
van der Molen T; Postma DS; Turner MO; Jong BM; Malo JL; Chapman K; Grossman R; de Graaff CS; Riemersma RA; Sears MR
Thorax; 1997 Jun; 52(6):535-9. PubMed ID: 9227720
[TBL] [Abstract][Full Text] [Related]
37. Oral beta 2-selective adrenergic bronchodilators.
Grassi V; Daniotti S; Schiassi M; Dottorini M; Tantucci C
Int J Clin Pharmacol Res; 1986; 6(2):93-103. PubMed ID: 2873108
[TBL] [Abstract][Full Text] [Related]
38. Possible site of bronchodilation due to inhaled procaterol aerosol in asthmatic patients.
Taguchi O; Hida W; Nogami H; Inoue H; Takishima T
Eur J Clin Pharmacol; 1988; 34(5):433-7. PubMed ID: 2974417
[TBL] [Abstract][Full Text] [Related]
39. Prednisolone oral solution plus inhaled procaterol for acute asthma in children: a double-blind randomized controlled trial.
Huang LH; Shyur SD; Wen DC; Chang YC; Ma YC; Lin SC; Wu WC; Wu JY
Acta Paediatr Taiwan; 2007; 48(5):257-62. PubMed ID: 18254574
[TBL] [Abstract][Full Text] [Related]
40. Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily living.
Shioya T; Satake M; Sato K; Sano MA; Sugawara K; Takahashi H; Honma M
Arzneimittelforschung; 2008; 58(1):24-8. PubMed ID: 18368947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
